A Phase III Study to Evaluate the Efficacy and Safety of Benralizumab in Patients With Hypereosinophilic Syndrome (HES)
Clinical trial NCT04191304 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04191304
- Sponsor
- AstraZeneca
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-20
- Primary completion
- 2025-05-07
- Enrollment
- 134
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.